AdvisorShares Investments LLC lowered its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 28.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,151 shares of the biopharmaceutical company’s stock after selling 1,621 shares during the period. AdvisorShares Investments LLC’s holdings in Intra-Cellular Therapies were worth $297,000 at the end of the […]